Start here and hope there's convenient location near you.
https://clinicaltrials.gov/study/NCT06872892
For what it's worth, some pulmonologists believe Boehringer-Ingelheim's Verducatib (Airtivity trial) will be a better drug than Insmed's Brinuspri, but not available until 2029 if approved. If I weren't on Brinsupri I'd make sure to be enrolled in this trial and hope I did not get the placebo!

Boehringer-Ingelheim is currently recruiting all over the world!